Identification of cellular receptors used by coronavirus (CoV) entry into the host cells is 21 critical to understand pathogenesis and to develop intervention strategies. The fourth CoV 22 genus, Deltacoronavirus, evolutionally related to the Gammacoronavirus, has just been 23 defined recently. In the current study, we demonstrate that porcine aminopeptidase N (pAPN) 24 acts as a cross-genus CoV functional receptor for both enteropathogenic porcine DeltaCoV 25 (PDCoV) and AlphaCoV (transmissible gastroenteritis virus, TGEV) based upon three lines 26 of evidences. First, the soluble S1 protein of PDCoV efficiently bound to surface of target 27 porcine cell lines known to express pAPN as TGEV-S1 did, which could be blocked by 28 soluble pAPN pre-treatment. Second, either PDCoV-S1 or TGEV-S1 physically recognized 29 and interacted with pAPN by co-immunoprecipitation in pAPN-cDNA-transfected cells and 30 by dot blot hybridization assay. Finally, exogenous expression of pAPN in refractory cells 31 conferred susceptibility to PDCoV-S1 binding and for PDCoV entry and productive 32 infection. PDCoV-S1 appeared to have a lower pAPN-binding affinity and likely consequent 33 lower infection efficiency in pAPN-expressing refractory cells as compared to TGEV-S1, 34
adhesion molecule 1 (CEACAM1), (iii) angiotensin converting enzyme 2 (ACE2), and (iv) 85 dipeptidyl peptidase 4 (DPP4) for three distinct BetaCoVs, mouse hepatitis virus (MHV) 86 (10), severe acute respiratory syndrome coronavirus (SARS-CoV) (11) and Middle East 87 respiratory syndrome coronavirus (MERS-CoV) (12), respectively. Interestingly, the human 88 ACE2 can also serve as the entry receptor for AlphaCoV human coronavirus (HCoV) NL63 89 in addition to . These receptors interact with the amino-terminal receptor-90 binding domain S1 of specific CoV S glycoproteins, which determined the cross-species 91 transmission and infection of . 92
While functional receptors for the representative members in Alphacoronavirus and 93
Betacoronavirus have been continuously discovered, receptors for Gammacoronavirus and 94
Deltacoronavirus are still unknown. In the current study, we demonstrate that, similar to 95 ACE2, porcine APN (pAPN) acts as a cross-genus CoV functional receptor for both porcine 96 DeltaCoV (PDCoV) and AlphaCoV (TGEV) based upon three lines of evidences. First, the 97 soluble Fc-fusion S1 protein of PDCoV efficiently bound to the surface of target porcine cell 98 lines known to express pAPN as TGEV-S1-Fc did, which could be blocked by soluble pAPN 99 pre-treatment. Second, either PDCoV-S1 or TGEV-S1 physically recognized and interacted 100 with pAPN by co-immunoprecipitation (IP) in pAPN-cDNA-transfected cells and by dot blot 101 hybridization assay. Finally, exogenous expression of pAPN in refractory cells conferred 102 6 was initially isolated and propagated in these two cell lines (3, 4), suggesting a common cell 110 tropism of TGEV and PDCoV. In addition, neither African green monkey Vero cells (ATCC 111 CCL-81) nor hamster BHK-21 cells are permissive for TGEV or PDCoV infection in vitro in 112 our lab. To investigate whether PDCoV-S1 determines the cell tropism as that documented 113 for TGEV-S1 (14), we generated the S1-human Fc (hFc) chimeric proteins from PDCoV 114 (Chinese/Hunan strain; GenBank accession no. KY513724) and TGEV (prototype Purdue 115 strain) (5), respectively. As expected, soluble TGEV-S1-hFc bound to target LLC-PK1 or ST 116 cells, but not to non-susceptible Vero or BHK-21 cells by using flow cytometry analysis (Fig.  117 1A). Next we tested the binding of soluble PDCoV-S1 under the same conditions. 118
Comparison of cellular surface binding of PDCoV-S1-hFc to LLC-PK1 or ST cells indicated 119 significant similarities with TGEV-S1 binding, whereas S1-hFc binding was not detected in 120
Vero or BHK-21 cells (Fig. 1B) , which is correlated with infection of PDCoV. 121
We further confirmed that both LLC-PK1 and ST cells had endogenous expression of 122 pAPN whereas Vero or BHK-21 cells lacked APN counterpart expression by western blotting 123 (WB) analysis using a broadly reactive anti-APN antibody (Ab) (Fig. 1C) . As controls, two 124 stable cell lines Vero-pAPN and BHK-pAPN, both expressing pAPN, were established, by 125 transfection with a recombinant construct, pAPN-Myc, expressing full-length pAPN cDNA 126 fused with a Myc tag at the C-terminus, followed by selection with puromycin. Expression of 127 pAPN was detected in Vero-pAPN cells (Fig. 1C) . Comparison of APN expression between 128 BHK-21 cells and BHK-pAPN had the similar result, showing pAPN expression only in 129 BHK-pAPN cells (Fig. 1C) . Thus, LLC-PK1 and ST cells are susceptible to both TGEV-S1 130 and PDCoV-S1 binding, permissive to both TGEV and PDCoV infection and express the 131 TGEV receptor pAPN, whereas Vero and BHK-21 cells are not susceptible to binding, not 132 permissive to infection and do not express APN. 133
Interaction between PDCoV-S1/TGEV-S1 and pAPN associated with cell tropism. 134
The interaction between PDCoV-S1 and pAPN was analyzed by co-IP. BHK-21 cells were 135 on April 4, 2018 by KENT STATE UNIV LIBRARY http://jvi.asm.org/ Downloaded from 7 transfected with PDCoV-S1-hFc or TGEV-S1-hFc expression construct alone, or an empty 136 vector expressing hFc alone, or co-transfected of each hFc construct with pAPN-Myc 137 plasmid. Expression of transfected Fc-tagged proteins and pAPN were confirmed in whole 138 cell lysates by WB with anti-Fc Ab and anti-Myc Ab, respectively ( Fig. 2A, bottom) . The 139 transfected BHK21 cells were then immunoprecipitated with Fc tag preadsorbed onto protein 140
A conjugated agarose beads. The bound protein complexes were subjected to WB analysis 141 with anti-Myc Ab or anti-Fc Ab. As shown in Fig. 2A (top) , pAPN-Myc bound specifically 142 to either PDCoV-S1-hFc or TGEV-S1-hFc. In contrast, pAPN-Myc did not bind to the 143 control hFc protein (lanes 3 and 5). Notably, the amount of pAPN-Myc brought down by 144
PDCoV-S1-hFc (lane 4, top) was significantly less than that was brought down by TGEV-S1-145 hFc (lane 6, top), whereas the expression level of pAPN-Myc is more abundant in lane 4 than 146 in lane 6. Since equal amounts of plasmid DNA of PDCoV-S1-hFc and TGEV-S1-hFc were 147 input for the IP experiment, as shown by no significant difference in the detection level 148 between S1-Fc proteins either in IP or in whole cell lysates (WCL) ( Fig. 2A) , the IP result 149
suggests that PDCoV-S1 may have a lower pAPN-binding affinity than TGEV-S1. 150
To further validate the specific interaction between PDCoV-S1 and pAPN, a dot blot 151 hybridization assay was conducted. It was shown that both TGEV-S1-hFc and PDCoV-S1-152 hFc efficiently bound to the soluble pAPN ectodomain tagged with a mouse Fc (pAPN-mFc) 153 but not to the mFc control. On the other hand, the hFc bound to neither pAPN-mFc nor mFc 154 (Fig. 2B) . These results demonstrated that either PDCoV-S1 or TGEV-S1 physically 155 recognized and interacted with pAPN., 156
Next, the soluble pAPN-mFc or mFc was preincubated with TGEV-S1-hFc, PDCoV-S1-157 hFc or hFc; the LLC-PK1 or ST cells were then subjected to flow cytometry analysis with the 158 mixtures as described in Fig. 1A and 1B. Treatment of S1-hFc with pAPN-mFc but not mFc 159 blocked surface binding (Fig. 3A) , indicating that PDCoV-S1 or TGEV-S1 does employ 160 pAPN for cellular binding on host ( (Fig. 1C) . 168
Furthermore, surface expression of pAPN on Vero-pAPN or BHK-pAPN was validated by 169 detection of efficient binding of TGEV-S1-hFc or PDCoV-S1-hFc by flow cytometry 170 analysis, which could be blocked by soluble pAPN-mFc pre-treatment ( Fig. 3B ), similar to 171 what was observed in LLC-PK1 or ST cells (Fig. 3A) . In contrast, the two S1-hFc did not 172 bind to the parental cell lines (Fig. 3B) , which was in line with the result in Fig. 1A and 1B. 173
As controls, the two S1-hFc soluble proteins did not bind to Vero cells overexpressing the 174 SARS-CoV and HCoV-NL63 receptor ACE2 (11, 13) or BHK-21 cells exogenously 175 expressing ACE2 (Fig. 3B) . Therefore, exogenous expression of pAPN in refractory Vero or 176 BHK-21 cells conferred specific susceptibility to PDCoV-S1 or TGEV-S1 binding. In 177 addition, cytoplasmic expression of pAPN in Vero-pAPN or BHK-pAPN was also validated 178 by immunofluorescence assay (IFA) using anti-Myc Ab or anti-pAPN Ab ( (Fig. 4A, bottom) . A slightly 188 lower infection efficiency of PDCoV than that of TGEV could likely be accounted for by the 189 possibly lower pAPN-binding affinity of PDCoV-S1 ( Fig. 2A) . Development of cytopathic 190 effects characterized by cell rounding, aggregation and subsequent detachment in infected Vero-pAPN cells was observed (Fig. 4B) . PDCoV secreted from Vero-pAPN cells could be passaged (Fig. 6B) . Progeny PDCoV 210 infection of fresh LLC-PK1 cells was also validated by IFA using an anti-PDCoV-N Ab (Fig.  211   6C) . The PDCoV growth curve in Vero-pAPN cells was lower than that in control LLC-PK1 212 on April 4, 2018 by KENT STATE UNIV LIBRARY http://jvi.asm.org/ Downloaded from 10 cells; but reached the peak titers in the period of 48-72 hpi (5.12 log 10 TCID 50 /ml and 6.27 213 log 10 TCID 50 /ml, respectively) 214
For comparison of infection efficiency, we also determined the growth kinetics of TGEV 215 secreted from Vero-pAPN, Vero or from control LLC-PK1 cells on fresh LLC-PK1 cells 216 (Fig. 6B) . No TGEV was produced in Vero cells. In control LLC-PK1 cells, extracelluar 217
TGEV had a growth curve with virus titers analogous to extracelluar PDCoV, while for Vero-218 pAPN cells inoculated with either TGEV or PDCoV, extracelluar TGEV propagated more 219 efficiently than extracelluar PDCoV, reaching a peak titer at 48 hpi (5.67 log 10 TCID 50 /ml), 220
and with approximately 3-to 10-fold higher titers during 6-48 hpi (Fig. 6B) . The kinetics data 221 was consistent with the distinct expression level of N proteins between TGEV and PDCoV 222 (Fig. 4A) . More recently, a near atomic-resolution cryo-electron microscopy structure of PDCoV S 274 glycoprotein trimer has revealed that the PDCoV RBD displays a β-sandwich fold 275 reminiscent of that of AlphaCoVs, harboring topologically similar glycosylation sites on the 276 β-sandwich surface (19). Several aromatic residues (Phe-318, Tyr-394, at the protruding tips have also been speculated to mediate receptor-RBD interaction (19) . 278
However, since PDCoV can also infect some human cell lines such as Huh-7 expressing 279 hAPN in vitro (preliminary data not shown), and calves in vivo (30), and could be detected in 280
Asian leopard cats and Chinese ferret badgers (31), we hypothesize that PDCoV can utilize 281
APNs from the other mammalian species as the receptor, which distinguishes TGEV and 282
HCoV-229E in usage of host-specific APN. If so, the VBM in APN recognized by PDCoV-283 S1 may be different from VBM1 by HCoV-229E or VBM2 recognized by TGEV. This 284 hypothesis is also supported by the experimental data from this study, where we found that 285 the results of co-IP, IFA and comparative growth kinetics ( Fig. 2A, Fig. 4A and Fig. 6B Since Deltacoronavirus is believed to originate from avian CoVs (2), our result also 295 raises a question whether the APN counterparts in avian species play a role in PDCoV cross-296 species transmission. Nevertheless, the present study suggests that PDCoV has evolved a 297 mechanism that utilizes pAPN as its entry receptor to expand host range. The identification of 298 pAPN as a functional receptor used by PDCoV paves the way for dissecting the molecular 299 mechanisms of PDCoV-host interactions and pathogenesis as well as facilitates future 300 vaccine development and intervention strategies against PDCoV infection. Anti-PDCoV-nucleocapsid (N) monoclonal antibody (mAb) was purchased from 322
Medgene Labs (Brookings, SD, USA), whereas anti-TGEV-N polyclonal antibody (pAb) was 323 generated in-house. Briefly, the full-length N protein of TGEV with a 6 × histidine tag 324 expressed in E. coli was purified and used to immunize two New Zealand White rabbits. 325
Antisera were harvested and affinity purified at 55 days postimmunization. Flow cytometry analysis. We followed the protocol as described previously in ref. (21). 354 Briefly, soluble hFc and mFc fusion proteins (TGEV-S1-hFc, PDCoV-S1-hFc, hFc, mFc and 355 pAPN-mFc) were transiently expressed in 293T cells and affinity purified from the 356 supernatant medium using protein A sepharose beads (Transbionovo, Beijing, China), 357 respectively. Analysis of purified proteins was performed by sodium dodecyl sulfate 358 polyacrylamide gel electrophoresis (SDS-PAGE) to ensure the purity and quality (data not 359 shown). Binding of soluble Fc proteins to surface of given cells was performed by incubation 360 with 10 µg/ml of purified S1-hFc proteins followed by detection with a FITC-conjugated 361 anti-human IgG Fc Ab (Thermo Fisher Scientific) by flow cytometer. Blocking of S1-hFc 362 was performed by preincubation with soluble pAPN-mFc or mFc for 2 h prior to conducting 363 surface binding assay. 
